These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22506790)

  • 1. Circulating nucleic acids and protease activities in blood of tumor patients.
    Schwarzenbach H
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S163-9. PubMed ID: 22506790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
    Roth C; Pantel K; Müller V; Rack B; Kasimir-Bauer S; Janni W; Schwarzenbach H
    BMC Cancer; 2011 Jan; 11():4. PubMed ID: 21211028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating nucleic acids in plasma/serum and tumor progression: are apoptotic bodies involved? An experimental study in a rat cancer model.
    Samos J; García-Olmo DC; Picazo MG; Rubio-Vitaller A; García-Olmo D
    Ann N Y Acad Sci; 2006 Sep; 1075():165-73. PubMed ID: 17108207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.
    Chan KC; Lo YM
    Br J Cancer; 2007 Mar; 96(5):681-5. PubMed ID: 17311021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease signaling in tumor progression.
    Camerer E
    Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
    Taback B; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Peptidome and Tumor-Resident Proteolysis.
    Fan J; Ning B; Lyon CJ; Hu TY
    Enzymes; 2017; 42():1-25. PubMed ID: 29054266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
    García-Olmo DC; Ruiz-Piqueras R; García-Olmo D
    Histol Histopathol; 2004 Apr; 19(2):575-83. PubMed ID: 15024717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
    Friel AM; Corcoran C; Crown J; O'Driscoll L
    Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of proteolytic enzymes in skin neoplasm progression and development of metastasis].
    Kozłowski L; Wojtukiewicz MZ
    Postepy Hig Med Dosw; 1999; 53(6):841-54. PubMed ID: 10737043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating nucleic acids as a tumor marker.
    Chan KC; Lo YM
    Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application status of circulating nucleic acids as biomarkers in gastric cancer].
    Li L; Zhang L; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):21-5. PubMed ID: 24519044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.
    Rykova EY; Morozkin ES; Ponomaryova AA; Loseva EM; Zaporozhchenko IA; Cherdyntseva NV; Vlassov VV; Laktionov PP
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S141-53. PubMed ID: 22500614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging of tumor proteolysis.
    Sloane BF; Sameni M; Podgorski I; Cavallo-Medved D; Moin K
    Annu Rev Pharmacol Toxicol; 2006; 46():301-15. PubMed ID: 16402907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating nucleic acids in cancer and pregnancy.
    Pinzani P; Salvianti F; Pazzagli M; Orlando C
    Methods; 2010 Apr; 50(4):302-7. PubMed ID: 20146940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic markers in cancer.
    Holdenrieder S; Stieber P
    Clin Biochem; 2004 Jul; 37(7):605-17. PubMed ID: 15234242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer.
    Roth C; Kasimir-Bauer S; Pantel K; Schwarzenbach H
    Mol Oncol; 2011 Jun; 5(3):281-91. PubMed ID: 21398193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
    Stoetzer OJ; Wittwer C; Lehner J; Fahmueller YN; Kohles N; Fersching DM; Leszinski G; Roessner J; Holdenrieder S
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S217-24. PubMed ID: 22620489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic transformation induced by cell-free nucleic acids circulating in plasma (genometastasis) remains after the surgical resection of the primary tumor: a pilot study.
    García-Olmo D; García-Olmo DC; Domínguez-Berzosa C; Guadalajara H; Vega L; García-Arranz M
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S61-8. PubMed ID: 22568822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.